Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

BLOCK ASPIRIN/SALICYLAMIDE COMBO RELIEVES PAIN 17 MINUTES "SOONER" than aspirin alone, Block Drug reported in a study submitted to FDA to support monograph status of 195 mg salicylamide as an analgesic adjuvant to 650 mg aspirin. Conducted by Stephen Cooper, PhD, et al., the double blind, randomized, parallel group study compared efficacy profiles for four preparations -- placebo, 650 mg aspirin, 650 mg aspirin with 195 mg salicylamide, and 1,300 mg aspirin -- and found that onset of pain relief "occurred 17 minutes sooner" in the aspirin/salicylamide group than in the 650 mg aspirin group. Block Drug markets BC Powder analgesic product which contains the aspirin/salicylamide combination.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts